Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study

Abstract Background Steatotic liver disease (SLD) was a newly proposed disease category derived from metabolic dysfunction-associated fatty liver disease (MAFLD). MAFLD and sarcopenia were independent risk factors for mortality. We aimed to evaluate the impacts of SLD subtypes, MAFLD, and sarcopenia...

Full description

Bibliographic Details

Published in:	BMC Gastroenterology
Main Authors:	Yebei Liang, Xiaoqi Ye, Min Pan, Yijun Chen, Yeqing Yuan, Li Luo
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Subjects:	Steatotic liver disease Metabolic dysfunction-associated steatotic liver disease Metabolic dysfunction and alcohol-associated liver disease Metabolic dysfunction-associated fatty liver disease Sarcopenia Mortality
Online Access:	https://doi.org/10.1186/s12876-025-03661-0